
Podcast #41 · 30 Dec 2025
Advanced Pancreatic Cancer: Systemic Therapy Strategies
- Medical Oncology
- KRAS Mutation
- Pancreatic Enzyme Replacement Therapy (PERT)
- Pathology
- Metastatic Pancreatic Cancer
- Clinical Trials
- Next-Generation Sequencing (NGS)
- Healthcare Disparities
- Palliative Care
- Germline Testing
Metastatic pancreatic cancer is no longer a ‘one size fits all’ diagnosis. In this episode of the BackTable Tumor Board Podcast, medical oncologist Dr. Jon Mizrahi and Dr. Shubham Pant, a professor of GI Medical Oncology at MD Anderson Cancer Center, discuss the evolving landscape of systemic therapy for advanced pancreatic cancer.
Timestamps
Resources
More about this episode
The doctors cover the current options for first- and second-line chemotherapy treatments, the significance of molecular profiling and germline testing, and the emerging potential of targeting KRAS mutations. The discussion also highlights the importance of supportive and palliative care for patients, focusing on pain management, nutritional support, and the role of pancreatic enzymes. The conversation concludes with speculation on the future of pancreatic cancer treatment and the need for improved access to clinical trials.

